Skip to main content
TipRanks
Go Ultimate75% OFF

CapsoVision, Inc. (CV) Stock Price & Analysis

27 Followers

CV Stock Chart & Stats

$6.31-$0.51(-7.48%)
At close: 4:00 PM EST
$6$6.5$7Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$6.28 - $6.83
52-Week Range
$4.50 - $15.37
Previous Close
$6.82
Volume
N/A
Average Volume (3M)
129.52K
Market Cap
$365.62M
Enterprise Value
$305.69M
Total Cash (Recent Filing)
$21.76M
Total Debt (Recent Filing)
$780.00K
Price to Earnings (P/E)
―
Beta
-1.15
Next Earnings
Apr 01, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Differentiated AI Imaging Platform

The combination of panoramic small-bowel imaging and FDA-cleared AI review differentiates CapsoVision’s product from competing capsules. This integrated capability may improve physician efficiency, support clinical adoption, and strengthen the company’s competitive position across hospitals and GI practices.

Regulatory And Product Expansion

FDA clearance and the U.S. launch expand the commercial utility of CapsoCam Plus and validate the company’s development platform. Embedding AI into CapsoView and CapsoCloud can deepen the existing workflow proposition while creating a foundation for broader product adoption.

Revenue Growth With Solid Gross Margins

Sustained trailing revenue growth alongside solid gross margins indicates that the core product has meaningful commercial demand and reasonable underlying economics. If maintained, this combination can support reinvestment in regulatory programs, sales expansion, and future operating leverage.

Bears Say

Significant And Worsening Cash Burn

Persistent negative operating and free cash flow means the business is not yet funding operations internally. The worsening burn increases dependence on financing resources, limits flexibility to invest through a downturn, and raises the importance of achieving meaningful revenue scale and expense discipline.

Very Large Operating And Net Losses

Losses that substantially exceed revenue show that the current cost base is far ahead of the company’s commercial scale. This weak operating leverage can delay profitability, consume available capital, and make future earnings highly dependent on rapid adoption and sustained expense reductions.

Pricing And Margin Pressure

Competitive pricing and a lower quarterly gross margin indicate pressure on the economics of the current product portfolio. Unless product differentiation and scale offset this pressure, constrained gross profit could slow progress toward profitability and reduce funds available for clinical and commercial expansion.

CapsoVision, Inc. News

CV FAQ

What was CapsoVision, Inc.’s price range in the past 12 months?
CapsoVision, Inc. lowest stock price was $4.50 and its highest was $15.37 in the past 12 months.
What is CapsoVision, Inc.’s market cap?
CapsoVision, Inc.’s market cap is $365.62M.
When is CapsoVision, Inc.’s upcoming earnings report date?
CapsoVision, Inc.’s next earnings report is estimated for Apr 01, 2027 (not yet confirmed), which is in 132 days.
How were CapsoVision, Inc.’s earnings last quarter?
CapsoVision, Inc. released its earnings results on Nov 12, 2026. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.147 by -$0.003.
Is CapsoVision, Inc. overvalued?
According to Wall Street analysts CapsoVision, Inc.’s price is currently Undervalued.
Does CapsoVision, Inc. pay dividends?
CapsoVision, Inc. does not currently pay dividends.
What is CapsoVision, Inc.’s EPS estimate?
CapsoVision, Inc.’s EPS estimate is -0.12.
How many shares outstanding does CapsoVision, Inc. have?
CapsoVision, Inc. has 53,609,720 shares outstanding.
What happened to CapsoVision, Inc.’s price movement after its last earnings report?
CapsoVision, Inc. reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.147. Following the earnings report the stock price went down -3.828%.
Which hedge fund is a major shareholder of CapsoVision, Inc.?
Hedge funds hold CapsoVision, Inc. shares: the largest hedge-fund position in CapsoVision, Inc. is 71,884,351 shares, and hedge funds increased their holdings by 591.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology